Skip to main content
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 05, 2008; 71 (6) Articles

Dehydroepiandrosterone for myotonic dystrophy type 1

I. Pénisson-Besnier, M. Devillers, R. Porcher, D. Orlikowski, V. Doppler, C. Desnuelle, X. Ferrer, M. -C.A. Bes, F. Bouhour, C. Tranchant, E. Lagrange, A. Vershueren, D. Uzenot, P. Cintas, G. Solé, J. -Y. Hogrel, P. Laforêt, C. Vial, A. L. Vila, S. Sacconi, J. Pouget, B. Eymard, S. Chevret, D. Annane
First published August 4, 2008, DOI: https://doi.org/10.1212/01.wnl.0000324257.35759.40
I. Pénisson-Besnier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Devillers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Porcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Orlikowski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Doppler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Desnuelle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X. Ferrer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. -C.A. Bes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Bouhour
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Tranchant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Lagrange
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Vershueren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Uzenot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Cintas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Solé
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. -Y. Hogrel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Laforêt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Vial
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. L. Vila
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Sacconi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Pouget
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Eymard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Chevret
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Annane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Dehydroepiandrosterone for myotonic dystrophy type 1
I. Pénisson-Besnier, M. Devillers, R. Porcher, D. Orlikowski, V. Doppler, C. Desnuelle, X. Ferrer, M. -C.A. Bes, F. Bouhour, C. Tranchant, E. Lagrange, A. Vershueren, D. Uzenot, P. Cintas, G. Solé, J. -Y. Hogrel, P. Laforêt, C. Vial, A. L. Vila, S. Sacconi, J. Pouget, B. Eymard, S. Chevret, D. Annane
Neurology Aug 2008, 71 (6) 407-412; DOI: 10.1212/01.wnl.0000324257.35759.40

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
327

Share

  • Article
  • Figures & Data
  • Info & Disclosures
  • CME Course
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Background: Myotonic dystrophy type 1 may be associated with low circulating dehydroepiandrosterone (DHEA) levels. This study was aimed at investigating the efficacy and safety of DHEA in myotonic dystrophy type 1 patients.

Methods: This was a prospective, multicenter, randomized, double-blind, placebo-controlled trial conducted from February 2005 to January 2006 at 10 university-affiliated neuromuscular disease centers in France. Seventy-five ambulatory adults with myotonic dystrophy type 1 received an oral replacement dose (100 mg/d) or a pharmacologic dose (400 mg/d) of DHEA, or placebo. The primary endpoint was the relative change in the manual muscle testing (MMT) score from baseline to week 12. Secondary outcome measures included changes from baseline to week 12 in quantitative muscle testing and timed functional testing, respiratory and cardiac function, and quality of life. This study was registered with ClinicalTrials.gov identifier NCT00167609.

Results: The median (1st, 3rd quartile) relative changes in MMT score from baseline to week 12 after randomization were 3.1 (−0.9, 6.7), 1.9 (−2.7, 3.5), and 2.2 (0, 7.9), in the DHEA 100 mg, DHEA 400 mg, and placebo groups, respectively. There were no differences between placebo and combined DHEA groups (p = 0.34), placebo and DHEA 100 mg (p = 0.86), or placebo and DHEA 400 mg (p = 0.15). There were also no evidence for a difference between groups for the changes from baseline to week 12 in any secondary outcome.

Conclusions: There is no evidence that a 12-week treatment with replacement or pharmacologic doses of dehydroepiandrosterone improves muscle strength in ambulatory myotonic dystrophy type 1 patients.

Glossary

BMI=
body mass index;
DHEA=
dehydroepiandrosterone;
DHEA-S=
dehydroepiandrosterone sulfate ester;
IQR=
interquartile range;
MIRS=
muscular impairment rating scale;
MMT=
manual muscle testing;
PSA=
prostate-specific antigen;
SF36=
Short Form 36.
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • METHODS
    • RESULTS
    • DISCUSSION
    • AFFILIATIONS
    • AUTHOR CONTRIBUTIONS
    • ACKNOWLEDGMENT
    • APPENDIX
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
  • CME Course

More Online

CME Course

Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials

Dr. Nicole Sur and Dr. Mausaminben Hathidara

► Watch

Topics Discussed

  • All Clinical Neurology
  • All Neuromuscular Disease
  • Clinical trials Randomized controlled (CONSORT agreement)

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy
    J. Mathieu, H. Boivin, D. Meunier et al.
    Neurology, February 13, 2001
  • Article
    A Prospective, Quantitative Study of the Natural History of Facioscapulohumeral Muscular Dystrophy (FSHD)
    Implications for Therapeutic Trials
    et al.
    Neurology, January 01, 1997
  • Articles
    Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
    E. J. Sorenson, A. J. Windbank, J. N. Mandrekar et al.
    Neurology, November 24, 2008
  • Articles
    Pentoxifylline as a rescue treatment for DMD
    A randomized double-blind clinical trial
    D.M. Escolar, A. Zimmerman, T. Bertorini et al.
    Neurology, March 07, 2012
Neurology: 100 (22)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise